Metabolic Therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
52
NCT03490786
A Dose Escalating Study to Assess the Safety and Tolerability of GT-001
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 16, 2017
Completion: Oct 2, 2017
NCT05110664
APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE
Phase: N/A
Role: Collaborator
Start: Feb 28, 2022
Completion: Oct 31, 2022
Loading map...